SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:DiVA.org:su-57533"
 

Search: id:"swepub:oai:DiVA.org:su-57533" > Cognitive functions...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone

Hirvikoski, Tatja (author)
Karolinska Institutet
Nordenstrom, Anna (author)
Karolinska Institutet
Lindholm, Torun (author)
Mälardalens högskola,Stockholms universitet,Psykologiska institutionen,Institutionen för samhälls- och beteendevetenskap,Stockholm University, Stockholm, Sweden
show more...
Lindblad, Frank (author)
Karolinska Institutet
Ritzen, E. Martin (author)
Karolinska Institutet
Wedell, Anna (author)
Karolinska Institutet
Lajic, Svetlana (author)
Karolinska Institutet
show less...
 (creator_code:org_t)
2006-12-05
2007
English.
In: Journal of Clinical Endocrinology and Metabolism. - : The Endocrine Society. - 0021-972X .- 1945-7197. ; 92:2, s. 542-548
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Context and Objective: In Sweden, from 1985 through 1995, 40 fetuses at risk for congenital adrenal hyperplasia (CAH) were treated with dexamethasone (DEX) to prevent virilization of affected females. We report long-term effects on neuropsychological functions and scholastic performance of this controversial treatment. Design and Patients: Prenatally treated children, 7 to 17 yr old, were assessed with standardized neuropsychological tests (A Developmental Neuropsychological Assessment and Wechsler Intelligence Scales for Children) and child-completed questionnaires measuring self-perceived scholastic competence (Self-Perception Profile for Children). A parent-completed questionnaire (Child Behavior Checklist/4-18 School Scale) was used to evaluate whether the treatment had any impact on the children's school performance. In addition, a child-completed questionnaire measuring social anxiety (The Social Anxiety Scale for Children-Revised) was completed by the prenatally treated children aged 8 to 17 yr (n = 21) and age- and sex-matched controls (n = 26). Results: Of 40 DEX-treated children, 26 (median age, 11 yr) participated in the study. Thirty-five sex- and age- matched healthy children were controls. There were no between-group differences concerning psychometric intelligence, measures of cerebral lateralization, memory encoding, and long-term memory. Short-term treated, CAH-unaffected children performed poorer than the control group on a test assessing verbal working memory (P = 0.003), and they rated lower on a questionnaire assessing self-perception of scholastic competence (P = 0.003). This group also showed increased self-rated social anxiety assessed by The Social Anxiety Scale for Children-Revised (P = 0.026). Prenatally treated, CAH-affected children performed poorer than controls on tests measuring verbal processing speed, although this difference disappeared when controlling for the child's full-scale IQ. Conclusions: This study indicates that prenatal DEX treatment is associated with previously not described long-term effects on verbal working memory and on certain aspects of self-perception that could be related to poorer verbal working memory. These findings may thus question future DEX treatment of congenital adrenal hyperplasia. Therefore, we encourage additional retrospective studies of larger cohorts to either confirm or challenge the present findings.

Subject headings

SAMHÄLLSVETENSKAP  -- Psykologi -- Tillämpad psykologi (hsv//swe)
SOCIAL SCIENCES  -- Psychology -- Applied Psychology (hsv//eng)

Keyword

corticotropin-releasing hormone
social-anxiety-scale
21-hydroxylase deficiency
11-beta-hydroxysteroid dehydrogenase
concurrent validity
fluid intelligence
working-memory
messenger-rna
follow-up
prevalence

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view